{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:09:04Z","timestamp":1790687344128,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009535","name":"Systembolaget AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003745","name":"Wilhelm och Martina Lundgrens Stiftelser","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014197","name":"Foundation Mary von Sydow born Wijk Donation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014552","name":"Adlerbertska Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ebiom.2026.106219","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:21:24Z","timestamp":1774286484000},"page":"106219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Tirzepatide attenuates mesolimbic cocaine-evoked dopamine levels and reduces cocaine taking, motivation and seeking behaviours in male rodents"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1995-2025","authenticated-orcid":false,"given":"Christian E.","family":"Edvardsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaynnam A.","family":"Emous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Adermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Witley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7557-7109","authenticated-orcid":false,"given":"Mia","family":"Ericson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath D.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Jerlhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2026.106219_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/SAR.S337338","article-title":"Cocaine Use Disorder (CUD): current clinical perspectives","volume":"13","author":"Schwartz","year":"2022","journal-title":"Subst Abuse Rehabil"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106219_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax1532","article-title":"The treatment of cocaine use disorder","volume":"5","author":"Kampman","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.ebiom.2026.106219_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06298.x","article-title":"The clinical significance of drug craving","volume":"1248","author":"Tiffany","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106219_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamapsychiatry.2022.1240","article-title":"Association of drug cues and craving with drug use and relapse: a systematic review and meta-analysis","volume":"79","author":"Vafaie","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2004.11.001","article-title":"Neurobiology of craving, conditioned reward and relapse","volume":"5","author":"Weiss","year":"2005","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1151\/spp05314","article-title":"The neurobiology of cocaine addiction","volume":"3","author":"Nestler","year":"2005","journal-title":"Sci Pract Perspect"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106219_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res Brain Res Rev"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106219_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040311","article-title":"The persistent challenge of developing addiction pharmacotherapies","volume":"11","author":"Swinford-Jackson","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106219_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","article-title":"The dopamine hypothesis of the reinforcing properties of cocaine","volume":"14","author":"Kuhar","year":"1991","journal-title":"Trends Neurosci"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106219_bib10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106219_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.109.001933","article-title":"Drug wanting: behavioral sensitization and relapse to drug-seeking behavior","volume":"63","author":"Steketee","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ebiom.2026.106219_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.11.005","article-title":"Gut-brain axis and addictive disorders: a review with focus on alcohol and drugs of abuse","volume":"196","author":"Jerlhag","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ebiom.2026.106219_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cobeha.2016.02.005","article-title":"GLP-1 influences food and drug reward","volume":"9","author":"Hayes","year":"2016","journal-title":"Curr Opin Behav Sci"},{"key":"10.1016\/j.ebiom.2026.106219_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.physbeh.2019.03.026","article-title":"Central GLP-1 receptors: novel molecular targets for cocaine use disorder","volume":"206","author":"Hernandez","year":"2019","journal-title":"Physiol Behav"},{"key":"10.1016\/j.ebiom.2026.106219_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107312","article-title":"IUPHAR review - glucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target","volume":"207","author":"Bruns Vi","year":"2024","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106219_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bph.15677","article-title":"The role of glucagon-like peptide 1 (GLP-1) in addictive disorders","volume":"179","author":"Kruse Klausen","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"15","key":"10.1016\/j.ebiom.2026.106219_bib17","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.cell.2024.06.003","article-title":"Transforming obesity: the advancement of multi-receptor drugs","volume":"187","author":"Kusminski","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106219_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069010","article-title":"The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106219_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/mp.2012.141","article-title":"GLP-1 analog attenuates cocaine reward","volume":"18","author":"Graham","year":"2013","journal-title":"Mol Psychiatry"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106219_bib20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/npp.2015.47","article-title":"Septal glucagon-Like peptide 1 receptor expression determines suppression of cocaine-induced behavior","volume":"40","author":"Harasta","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ebiom.2026.106219_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.physbeh.2015.06.013","article-title":"The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice","volume":"149","author":"Sorensen","year":"2015","journal-title":"Physiol Behav"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106219_bib22","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41386-018-0010-3","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats","volume":"43","author":"Hernandez","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106219_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/adb.12583","article-title":"Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats","volume":"24","author":"Hernandez","year":"2019","journal-title":"Addict Biol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106219_bib24","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1038\/s41380-020-00957-3","article-title":"GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA","volume":"26","author":"Hernandez","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106219_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr5051","article-title":"An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking","volume":"11","author":"Merkel","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.ebiom.2026.106219_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2025.07.001","article-title":"Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens","volume":"98","author":"Aranas","year":"2025","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106219_bib27","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/npp.2015.362","article-title":"Glucagon-Like Peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine","volume":"41","author":"Schmidt","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106219_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106219_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Frias","year":"2021","journal-title":"N Engl J Med"},{"issue":"10295","key":"10.1016\/j.ebiom.2026.106219_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106219_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106219_bib33","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1038\/s41380-025-03199-3","article-title":"Genetically modeled GLP1R and GIPR agonism reduce binge drinking and alcohol-associated phenotypes: a multi-ancestry drug-target Mendelian randomization study","volume":"30","author":"Reitz","year":"2025","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ebiom.2026.106219_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106119","article-title":"Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents","volume":"124","author":"Edvardsson","year":"2026","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2026.106219_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105684","article-title":"An inhibitory GLP-1 circuit in the lateral septum modulates reward processing and alcohol intake in rodents","volume":"115","author":"Edvardsson","year":"2025","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2026.106219_bib36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1749-6632.2001.tb03564.x","article-title":"Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse","volume":"937","author":"Becker","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106219_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jnr.23963","article-title":"Sex differences, gender and addiction","volume":"95","author":"Becker","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ebiom.2026.106219_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13877","article-title":"Dopaminergic dynamics underlying sex-specific cocaine reward","volume":"8","author":"Calipari","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106219_bib39","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae165","article-title":"GLP-1 and its analogs: does sex matter?","volume":"166","author":"Borchers","year":"2025","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106219_bib40","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00213-023-06367-x","article-title":"Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL\/6J mice","volume":"240","author":"Diaz-Megido","year":"2023","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106219_bib41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/mp.2017.187","article-title":"Lateral hypothalamic GLP-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight","volume":"23","author":"Lopez-Ferreras","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106219_bib42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2008.04.012","article-title":"Gender differences in cocaine dependence","volume":"97","author":"Najavits","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/dom.14843","article-title":"Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents","volume":"25","author":"Geisler","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ebiom.2026.106219_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106895","article-title":"Absorption, distribution, metabolism, and excretion of tirzepatide in humans, rats, and monkeys","volume":"202","author":"Martin","year":"2024","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106219_bib45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol Rev"},{"key":"10.1016\/j.ebiom.2026.106219_bib46","series-title":"Paxinos and Franklin's the mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2019"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106219_bib47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41386-019-0531-4","article-title":"Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats","volume":"45","author":"Zhang","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106219_bib48","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1038\/npp.2012.83","article-title":"Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats","volume":"37","author":"Hopkins","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ebiom.2026.106219_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109686","article-title":"PYY(3-36) infused systemically or directly into the VTA attenuates fentanyl seeking in male rats","volume":"239","author":"Caffrey","year":"2023","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106219_bib50","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2337\/db21-0459","article-title":"GIP receptor agonism attenuates GLP-1 receptor agonist-induced nausea and emesis in preclinical models","volume":"70","author":"Borner","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2026.106219_bib51","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/DMSO.S141235","article-title":"Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes","volume":"10","author":"Sikirica","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106219_bib52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/adb.12014","article-title":"Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats","volume":"19","author":"Kimmey","year":"2014","journal-title":"Addict Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainresrev.2004.04.009","article-title":"Regulation of affect by the lateral septum: implications for neuropsychiatry","volume":"46","author":"Sheehan","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.ebiom.2026.106219_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172831","article-title":"Sub-chronic taurine administration induces behavioral sensitization but does not influence ethanol-induced dopamine release in the nucleus accumbens","volume":"188","author":"Ulenius","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.ebiom.2026.106219_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2024.100184","article-title":"Subregion specific monoaminergic signaling in the female rat striatum during nicotine abstinence","volume":"13","author":"Lucente","year":"2024","journal-title":"Addiction Neuroscience"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106219_bib56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106219_bib57","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1037\/amp0000059","article-title":"Liking, wanting, and the incentive-sensitization theory of addiction","volume":"71","author":"Berridge","year":"2016","journal-title":"Am Psychol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106219_bib58","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106219_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J Comp Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106219_bib60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0196-9781(94)90016-7","article-title":"Gastric inhibitory polypeptide (GIP) binding sites in rat brain","volume":"15","author":"Kaplan","year":"1994","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106219_bib61","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jnr.21349","article-title":"Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain","volume":"85","author":"Nyberg","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ebiom.2026.106219_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.86","article-title":"Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels","volume":"6","author":"Reddy","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106219_bib63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10550490601184142","article-title":"Neurobiology of cocaine addiction: implications for new pharmacotherapy","volume":"16","author":"Kalivas","year":"2007","journal-title":"Am J Addict"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106219_bib64","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.npp.1300619","article-title":"Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration","volume":"30","author":"Stuber","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106219_bib65","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.neuron.2005.04.036","article-title":"Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens","volume":"46","author":"Stuber","year":"2005","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106219_bib66","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.neubiorev.2012.01.002","article-title":"The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments","volume":"36","author":"Milton","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.ebiom.2026.106219_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2010.08.003","article-title":"Central monoamine levels differ between rat strains used in studies of depressive behavior","volume":"1355","author":"Scholl","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.ebiom.2026.106219_bib68","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jchromb.2016.05.048","article-title":"Simultaneous quantification of monoamine neurotransmitters and their biogenic metabolites intracellularly and extracellularly in primary neuronal cell cultures and in sub-regions of Guinea pig brain","volume":"1028","author":"Schou-Pedersen","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2337\/db14-0668","article-title":"GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons","volume":"64","author":"Korol","year":"2015","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106219_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124765","article-title":"The GLP-1 receptor agonist Exendin-4 and diazepam differentially regulate GABAA receptor-mediated tonic currents in Rat hippocampal CA3 pyramidal neurons","volume":"10","author":"Korol","year":"2015","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.ebiom.2026.106219_bib71","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1523\/JNEUROSCI.0115-14.2014","article-title":"Glucagon-Like Peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA\/Kainate signaling","volume":"34","author":"Mietlicki-Baase","year":"2014","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106219_bib72","doi-asserted-by":"crossref","first-page":"E1367","DOI":"10.1152\/ajpendo.00413.2013","article-title":"The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA\/kainate receptors","volume":"305","author":"Mietlicki-Baase","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2026.106219_bib73","article-title":"Possible mechanisms underlying the effects of glucagon-like Peptide-1 receptor agonist on cocaine use disorder","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106219_bib74","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.celrep.2015.06.062","article-title":"Endogenous glucagon-like Peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons","volume":"12","author":"Wang","year":"2015","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106219_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170671","article-title":"The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission","volume":"8","author":"Chuong","year":"2023","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106219_bib76","doi-asserted-by":"crossref","first-page":"E472","DOI":"10.1152\/ajpendo.00250.2023","article-title":"Brain access of incretins and incretin receptor agonists to their central targets relevant for appetite suppression and weight loss","volume":"326","author":"Buller","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106219_bib77","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/bph.15638","article-title":"Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment","volume":"179","author":"Trapp","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106219_bib78","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1037\/pha0000620","article-title":"Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice","volume":"31","author":"Allingbjerg","year":"2023","journal-title":"Exp Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106219_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2026.106219_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109637","article-title":"Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging","volume":"238","author":"Skovbjerg","year":"2023","journal-title":"Neuropharmacology"},{"issue":"6040","key":"10.1016\/j.ebiom.2026.106219_bib81","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1204622","article-title":"Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area","volume":"333","author":"Luo","year":"2011","journal-title":"Science"},{"issue":"38","key":"10.1016\/j.ebiom.2026.106219_bib82","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1523\/JNEUROSCI.2277-12.2012","article-title":"Fos activation of selective afferents to ventral tegmental area during cue-induced reinstatement of cocaine seeking in rats","volume":"32","author":"Mahler","year":"2012","journal-title":"J Neurosci"},{"issue":"2\u20133","key":"10.1016\/j.ebiom.2026.106219_bib83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-0173(97)00009-X","article-title":"Connections of the rat lateral septal complex","volume":"24","author":"Risold","year":"1997","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.ebiom.2026.106219_bib84","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuropharm.2017.09.034","article-title":"Lateral septum stimulation disinhibits dopaminergic neurons in the antero-ventral region of the ventral tegmental area: role of GABA-A alpha 1 receptors","volume":"128","author":"Vega-Quiroga","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ebiom.2026.106219_bib85","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.neubiorev.2021.03.029","article-title":"Lateral septum as a nexus for mood, motivation, and movement","volume":"126","author":"Wirtshafter","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/adb.12297","article-title":"Involvement of lateral septum in alcohol's dopamine-elevating effect in the rat","volume":"22","author":"Jonsson","year":"2017","journal-title":"Addict Biol"},{"issue":"16","key":"10.1016\/j.ebiom.2026.106219_bib87","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.neuron.2024.06.004","article-title":"Cellular and circuit architecture of the lateral septum for reward processing","volume":"112","author":"Chen","year":"2024","journal-title":"Neuron"},{"issue":"19","key":"10.1016\/j.ebiom.2026.106219_bib88","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159863","article-title":"Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial","volume":"7","author":"Klausen","year":"2022","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106219_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194744","article-title":"GLP-1 physiology and pharmacology along the gut-brain axis","volume":"136","author":"Beutler","year":"2026","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib90","doi-asserted-by":"crossref","DOI":"10.1186\/s13293-016-0059-9","article-title":"Sex and estrogens alter the action of glucagon-like peptide-1 on reward","volume":"7","author":"Richard","year":"2016","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.ebiom.2026.106219_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104642","article-title":"Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats","volume":"93","author":"Aranas","year":"2023","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib92","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41398-020-00923-1","article-title":"Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats","volume":"10","author":"Vallof","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106219_bib93","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.cmet.2023.07.010","article-title":"GIPR\/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications","volume":"35","author":"Campbell","year":"2023","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106219_bib94","article-title":"Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R\/GIPR biased agonism yielding greater efficacy","volume":"6","author":"Rodriguez","year":"2025","journal-title":"Cell Rep Med"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106219_bib95","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s42255-025-01299-6","article-title":"Unravelling the GIPR agonist versus antagonist paradox","volume":"7","author":"Adriaenssens","year":"2025","journal-title":"Nat Metab"},{"key":"10.1016\/j.ebiom.2026.106219_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.599646","article-title":"Long-Acting glucagon-like Peptide-1 receptor agonists suppress voluntary alcohol intake in male wistar rats","volume":"14","author":"Marty","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ebiom.2026.106219_bib97","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/dom.70427","article-title":"GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models","volume":"28","author":"Baumer-Harrison","year":"2026","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-024-06637-2","article-title":"Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys","volume":"242","author":"Fink-Jensen","year":"2025","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106219_bib99","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial","volume":"82","author":"Hendershot","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib100","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41467-024-48780-6","article-title":"Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106219_bib101","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/add.16679","article-title":"The association between glucose-dependent insulinotropic polypeptide and\/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: a real-world data analysis","volume":"120","author":"Qeadan","year":"2025","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106219_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48267-2","article-title":"Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity","volume":"13","author":"Quddos","year":"2023","journal-title":"Sci Rep"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:00:02Z","timestamp":1783972802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":102,"alternative-id":["S2352396426001015"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106219","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tirzepatide attenuates mesolimbic cocaine-evoked dopamine levels and reduces cocaine taking, motivation and seeking behaviours in male rodents","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106219"}}